학술논문

Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study
Document Type
Article
Source
In: Blood. (Blood, 22 February 2024, 143(8):713-720)
Subject
Language
English
ISSN
15280020
00064971